Skip header and navigation

Narrow By

32 records – page 1 of 2.

Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0071
Available Online
View Pamphlet
The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aspirin
Subjects (LCSH)
Aspirin
Specialty
Medications
Abstract
The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0071
Less detail

Autologous stem cell transplant

https://libcat.nshealth.ca/en/permalink/chpams37470
Nova Scotia Health Authority. QEII. BMT Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0260
Available Online
View Pamphlet
This pamphlet provides information about the process of a stem cell transplant using your own stem cells. Informaton about stem cell transplants and stem cell collection is provided. Also included is information about before your stem cell collection, phases of the process, side effects of high dose chemotherapy, admission, moving to the Medical Day Unit (MDU), the importance of MedicAlert® identification, outpatient care, and what to expect after your transplant. Information on lodging, parki…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. BMT Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (63 p.) : digital, PDF file
Subjects (MeSH)
Stem Cell Transplantation
Transplantation, Autologous
Subjects (LCSH)
Transplantation of organs, tissues, etc.
Stem cells--Transplantation
Autotransplantation
Specialty
Hematology
Abstract
This pamphlet provides information about the process of a stem cell transplant using your own stem cells. Informaton about stem cell transplants and stem cell collection is provided. Also included is information about before your stem cell collection, phases of the process, side effects of high dose chemotherapy, admission, moving to the Medical Day Unit (MDU), the importance of MedicAlert® identification, outpatient care, and what to expect after your transplant. Information on lodging, parking, program policies, shingles, vaccinations, emotional health, healthy eating, and physical activity is also given.
Responsibility
Prepared by: QEII BMT Program
Pamphlet Number
0260
Less detail

Buprenorphine for opioid use disorder

https://libcat.nshealth.ca/en/permalink/chpams37561
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2267
Available Online
View Pamphlet
Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Buprenorphine
Opioid-Related Disorders - therapy
Subjects (LCSH)
Buprenorphine
Opioid abuse
Specialty
Medications
Abstract
Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2267
Less detail

Cannabinoïdes pour le traitement de la douleur

https://libcat.nshealth.ca/en/permalink/chpams35847
Nova Scotia Health Authority. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1792
Available Online
View Pamphlet
Les cannabinoïdes sont un groupe de médicaments parfois appelés « analgésiques à la marijuana » (antidouleurs) ou « cannabioïdes synthétiques » (artificiels). Ce dépliant explique pourquoi on vous a prescrit un cannabinoïde, la quantité et la façon de prendre ce médicament, les effets secondaires et la manière de rester en sécurité lorsque vous prenez ce médicament. Vous y trouverez également de l'information sur la conservation de ce médicament et sur ce qu'il faut faire en cas d'oubli d'une d…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pain Management Unit
Alternate Title
Cannabinoids for managing pain
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cannabinoids
Analgesics
Pain Management
Subjects (LCSH)
Cannabinoids
Analgesics
Pain--Treatment
Abstract
Les cannabinoïdes sont un groupe de médicaments parfois appelés « analgésiques à la marijuana » (antidouleurs) ou « cannabioïdes synthétiques » (artificiels). Ce dépliant explique pourquoi on vous a prescrit un cannabinoïde, la quantité et la façon de prendre ce médicament, les effets secondaires et la manière de rester en sécurité lorsque vous prenez ce médicament. Vous y trouverez également de l'information sur la conservation de ce médicament et sur ce qu'il faut faire en cas d'oubli d'une dose.
This pamphlet is a French translation of "Cannabinoid Analgesics for Pain Management" pamphlet 1350. Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included.
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
1792
Less detail

Cannabinoids for managing pain

https://libcat.nshealth.ca/en/permalink/chpams35259
Nova Scotia Health Authority. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1350
Available Online
View Pamphlet
Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included. The French version of this pamphlet 1792, "Cannabinoïdes pour le traitement …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pain Management Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cannabinoids
Analgesics
Pain Management
Subjects (LCSH)
Cannabinoids
Analgesics
Pain--Treatment
Specialty
Pain Management
Abstract
Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included. The French version of this pamphlet 1792, "Cannabinoïdes pour le traitement de la douleur", is also available.
Notes
Previous title: Cannabinoid analgesics for pain management
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
1350
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0249
Available Online
View Pamphlet
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Anticoagulants
Subjects (LCSH)
Anticoagulants (Medicine)
Specialty
Medications
Abstract
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0249
Less detail

Comment utiliser votre aérosol-doseur (pompe)

https://libcat.nshealth.ca/en/permalink/chpams35857
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1804
Available Online
View Pamphlet
Une explication de la façon de prendre soin de votre aérosol-doseur (pompe) et comment l’utiliser est fournie. Des conseils au sujet des médicaments et des exemples de pompes utilisées sont également présentés. Des rappels importants au sujet des aérosol-doseurs (pompes) sont également donnés. ; This pamphlet is a French translation of "How to Use Your Metered-Dose Inhaler (Puffer)" pamphlet 1694. An explanation of how to take care of your MDI and how to use it are provided. Medication tips and…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Alternate Title
How to use your metered-dose inhaler (puffer)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Nebulizers and Vaporizers
Asthma
Subjects (LCSH)
Inhalers
Asthma
Abstract
Une explication de la façon de prendre soin de votre aérosol-doseur (pompe) et comment l’utiliser est fournie. Des conseils au sujet des médicaments et des exemples de pompes utilisées sont également présentés. Des rappels importants au sujet des aérosol-doseurs (pompes) sont également donnés.
This pamphlet is a French translation of "How to Use Your Metered-Dose Inhaler (Puffer)" pamphlet 1694. An explanation of how to take care of your MDI and how to use it are provided. Medication tips and examples of puffers used are also listed. Important reminders about MDIs are also given.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
1804
Less detail

COVID-19 vaccine and cancer : third doses

https://libcat.nshealth.ca/en/permalink/chpams37496
Nova Scotia Health Authority. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2021.
Pamphlet Number
4009
Available Online
View Pamphlet
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
COVID-19 Vaccines
Neoplasms
Subjects (LCSH)
COVID-19 (Disease)
Vaccines
Cancer
Specialty
Cancer Care
Abstract
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program; Approved by: Nova Scotia Health Cancer Patient Education Committee
Pamphlet Number
4009
Less detail

HDR Brachytherapy for Esophagus Cancer

https://libcat.nshealth.ca/en/permalink/chpams37410
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1414
Available Online
View Pamphlet
Answers common questions about HDR brachytherapy for esophagus cancer including: what will happen the day of treatment, how is the treatment done, and what happens after treatment.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Alternate Title
High dose rate brachytherapy for esophagus cancer
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Brachytherapy
Esophageal Neoplasms - radiotherapy
Subjects (LCSH)
Esophagus--Cancer--Radiotherapy
Radioisotope brachytherapy
Specialty
Radiotherapy
Abstract
Answers common questions about HDR brachytherapy for esophagus cancer including: what will happen the day of treatment, how is the treatment done, and what happens after treatment.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1414
Less detail

HDR brachytherapy for gynecological cancers

https://libcat.nshealth.ca/en/permalink/chpams37402
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2024.
Pamphlet Number
4069
Available Online
View Pamphlet
This pamphlet explains what to expect after HDR (high-dose-rate) brachytherapy treatment for gynecological cancer. Topics include how to care for yourself, possible side effects, and when you should go to the Emergency room.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Alternate Title
High dose rate brachytherapy for gynecological cancers
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (]2] p.) : digital, PDF file
Subjects (MeSH)
Brachytherapy
Genital Neoplasms, Female - radiotherapy
Subjects (LCSH)
Generative organs, Female--Cancer--Radiotherapy
Radioisotope brachytherapy
Specialty
Cancer Care
Abstract
This pamphlet explains what to expect after HDR (high-dose-rate) brachytherapy treatment for gynecological cancer. Topics include how to care for yourself, possible side effects, and when you should go to the Emergency room.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4069
Less detail

HDR Brachytherapy for Gynecological (female) Cancers : Standard Inpatient Procedure

https://libcat.nshealth.ca/en/permalink/chpams37411
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1436
Available Online
View Pamphlet
Answers common questions about HDR brachytherapy for gynecological cancers including: what will happen the day of treatment, how is the treatment done, and what happens after treatment? For inpatients (patients admitted to hospital).
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Alternate Title
High dose rate brachytherapy for gynecological (female) cancers
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Brachytherapy
Genital Neoplasms, Female - radiotherapy
Subjects (LCSH)
Generative organs, Female--Cancer--Radiotherapy
Radioisotope brachytherapy
Specialty
Radiotherapy
Abstract
Answers common questions about HDR brachytherapy for gynecological cancers including: what will happen the day of treatment, how is the treatment done, and what happens after treatment? For inpatients (patients admitted to hospital).
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1436
Less detail

HDR Brachytherapy for Gynecological (female) Cancers : Standard Outpatient Procedure

https://libcat.nshealth.ca/en/permalink/chpams37404
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1331
Available Online
View Pamphlet
Answers common questions about HDR brachytherapy for gynecological cancers including: What will happen the day of treatment, how is the treatment done, and what happens after treatment? For outpatients (patients not admitted to hospital).
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Alternate Title
High dose rate brachytherapy for gynecological (female) cancers
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Brachytherapy
Genital Neoplasms, Female - radiotherapy
Outpatients
Subjects (LCSH)
Generative organs, Female--Cancer--Radiotherapy
Radioisotope brachytherapy
Specialty
Radiotherapy
Abstract
Answers common questions about HDR brachytherapy for gynecological cancers including: What will happen the day of treatment, how is the treatment done, and what happens after treatment? For outpatients (patients not admitted to hospital).
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1331
Less detail

HDR Brachytherapy for Gynecological (female) Cancers : Vault Procedure

https://libcat.nshealth.ca/en/permalink/chpams37403
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1330
Available Online
View Pamphlet
Answers common questions about HDR brachytherapy (vault procedure) given for gynecological cancers including what will happen the day of treatment, how is the treatment done, and what happens after treatment.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Alternate Title
High dose rate brachytherapy for gynecological (female) cancers
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (3 p.) : digital, PDF file
Subjects (MeSH)
Brachytherapy
Genital Neoplasms, Female - radiotherapy
Subjects (LCSH)
Generative organs, Female--Cancer--Radiotherapy
Radioisotope brachytherapy
Specialty
Radiotherapy
Abstract
Answers common questions about HDR brachytherapy (vault procedure) given for gynecological cancers including what will happen the day of treatment, how is the treatment done, and what happens after treatment.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1330
Less detail

How to use your metered-dose inhaler (MDI)

https://libcat.nshealth.ca/en/permalink/chpams35723
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1694
Available Online
View Pamphlet
An explanation of how to take care of your MDI and how to use it are provided. Medication tips and examples of puffers used are also listed. Important reminders about MDIs are also given. The French version of this pamphlet 1804, "Comment utiliser votre aérosol-doseur (pompe)", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (7 p.) : digital, PDF file
Subjects (MeSH)
Nebulizers and Vaporizers
Asthma
Subjects (LCSH)
Inhalers
Asthma
Abstract
An explanation of how to take care of your MDI and how to use it are provided. Medication tips and examples of puffers used are also listed. Important reminders about MDIs are also given. The French version of this pamphlet 1804, "Comment utiliser votre aérosol-doseur (pompe)", is also available.
Notes
Previous title: How to use your metered-dose inhaler (puffer)
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
1694
Less detail

How to use your metered-dose inhaler (MDI) with a spacer device

https://libcat.nshealth.ca/en/permalink/chpams35237
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1302
Available Online
View Pamphlet
An explanation of how to take care of your metered-dose inhaler (MDI) with a spacer device and the two ways you can use it are provided. Medication tips and examples of puffers used with a spacer device are listed. Important reminders about MDIs are also provided. The French version of this pamphlet 1374, "Comment utiliser votre inhalateur avec une chambre d’inhalation", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Nebulizers and Vaporizers
Asthma
Subjects (LCSH)
Inhalers
Asthma
Abstract
An explanation of how to take care of your metered-dose inhaler (MDI) with a spacer device and the two ways you can use it are provided. Medication tips and examples of puffers used with a spacer device are listed. Important reminders about MDIs are also provided. The French version of this pamphlet 1374, "Comment utiliser votre inhalateur avec une chambre d’inhalation", is also available.
Notes
Previous title: How to use your inhaler with a spacer device
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
1302
Less detail

Incidents liés à la sécurité des patients

https://libcat.nshealth.ca/en/permalink/chpams35745
Nova Scotia Health Authority. Quality and System Performance. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1712
Available Online
View Pamphlet
Les gens s'attendent à recevoir des soins de santé en toute sécurité. Tous les jours, les prestataires de soins de santé travaillent fort pour offrir d'excellents soins de santé, en toute sécurité. Malgré tous nos efforts pour assurer votre sécurité, être à l'hôpital comporte des risques. Les patients peuvent, par exemple, faire une chute, contracter une infection, développer une plaie de pression (plaie de lit) ou recevoir la mauvaise dose d'un médicament. Ces événements sont appelés incidents…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Quality and System Performance
Alternate Title
Talking about patient safety incidents
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Truth Disclosure
Risk Management
Subjects (LCSH)
Disclosure of information
Risk management
Abstract
Les gens s'attendent à recevoir des soins de santé en toute sécurité. Tous les jours, les prestataires de soins de santé travaillent fort pour offrir d'excellents soins de santé, en toute sécurité. Malgré tous nos efforts pour assurer votre sécurité, être à l'hôpital comporte des risques. Les patients peuvent, par exemple, faire une chute, contracter une infection, développer une plaie de pression (plaie de lit) ou recevoir la mauvaise dose d'un médicament. Ces événements sont appelés incidents liés à la sécurité des patients. Cette brochure explique ce que sont les incidents liés à la sécurité des patients, ce qu'il faut faire si vous constatez de tels incidents, comment les signaler, ce qu'est la divulgation, de quelle façon elle peut vous aider et comment elle a lieu. Une liste de ressources pour de plus amples renseignements est incluse.
This is a French translation of the English pamphlet 1448, "Patients First: Disclosure of Patient Safety Incidents". People expect safe health care. Health care providers work hard every day to give safe, excellent care. Despite our best efforts to keep you safe, there are risks to being in the hospital. For example, a patient may fall, or get an infection or a pressure injury (bedsore), or be given the wrong dose of medication. These events are called patient safety incidents. This pamphlet explains what patient safety incidents are, what to do if you notice a patient safety incident, how patient safety incidents are reported, what disclosure is and how it will help you, and how disclosure takes place. A list of resources for further information is included.
Notes
Previous title: Divulgation des incidents liés à la sécurité des patients
Responsibility
Prepared by: Quality Improvement and Safety
Pamphlet Number
1712
Less detail
Nova Scotia Health Authority. QE II. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1937
Available Online
View Pamphlet
Lithium is a mood stabilizer. It is most often used in bipolar disorder to prevent or treat mania or depression. This pamphlet explains what symptoms lithium will help with, how your dose of lithium is chosen, possible side effects, and signs of lithium toxicity (too much lithium).
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QE II. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Lithium - therapeutic use
Bipolar Disorder - drug therapy
Mania - drug therapy
Depression, Bipolar - drug therapy
Subjects (LCSH)
Lithium--Therapeutic use
Manic-depressive illness
Specialty
Medications
Abstract
Lithium is a mood stabilizer. It is most often used in bipolar disorder to prevent or treat mania or depression. This pamphlet explains what symptoms lithium will help with, how your dose of lithium is chosen, possible side effects, and signs of lithium toxicity (too much lithium).
Responsibility
Prepared by: Pharmacy Services, QE II
Pamphlet Number
1937
Less detail

Methadone for opioid use disorder

https://libcat.nshealth.ca/en/permalink/chpams37548
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2259
Available Online
View Pamphlet
Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Methadone
Subjects (LCSH)
Methadone hydrochloride
Specialty
Medications
Abstract
Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2259
Less detail

La méthadone pour traiter la douleur chronique

https://libcat.nshealth.ca/en/permalink/chpams37503
Nova Scotia Health Authority. QEII. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2193
Available Online
View Pamphlet
La méthadone est un analgésique opioïde (antidouleur). Elle est souvent utilisée pour gérer la douleur chronique. Ce dépliant explique comment et à quelle fréquence vous devez prendre la méthadone, ce qu’il faut faire si vous manquez une dose, comment conserver ce médicament et les précautions spéciales à prendre. Il décrit les effets secondaires et quand vous devez appeler votre fournisseur de soins primaires ou l’unité de traitement de la douleur. ; This pamphlet is a French translation of th…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pain Management Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Methadone
Analgesics, Opioid
Pain Management
Subjects (LCSH)
Methadone hydrochloride
Analgesics
Pain--Treatment
Abstract
La méthadone est un analgésique opioïde (antidouleur). Elle est souvent utilisée pour gérer la douleur chronique. Ce dépliant explique comment et à quelle fréquence vous devez prendre la méthadone, ce qu’il faut faire si vous manquez une dose, comment conserver ce médicament et les précautions spéciales à prendre. Il décrit les effets secondaires et quand vous devez appeler votre fournisseur de soins primaires ou l’unité de traitement de la douleur.
This pamphlet is a French translation of the English pamphlet 0686, "Using Methadone for Chronic Pain". Methadone is an opioid analgesic (painkiller). It is often used to manage chronic pain. This pamphlet explains how to take methadone, when to take it, and what to do if you miss a dose. Special precautions, side effects, storage instructions, and a list of symptoms that require a call to your primary health care provider's office or the Pain Management Unit are provided.
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
2193
Less detail

Nitroglycerin patch

https://libcat.nshealth.ca/en/permalink/chpams35947
Nova Scotia Health Authority. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0251
Available Online
View Pamphlet
This pamphlet explains what this medication is used for and how to take it. Other topics include: what do if you miss a dose, storage, drugs and foods to avoid, and warnings. Serious side effects which require a doctor's visit are listed. The French version of this pamphlet 1911, "Timbre de nitroglycérine", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Department
Alternate Title
Nitro patch
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Nitroglycerin
Subjects (LCSH)
Nitroglycerin
Abstract
This pamphlet explains what this medication is used for and how to take it. Other topics include: what do if you miss a dose, storage, drugs and foods to avoid, and warnings. Serious side effects which require a doctor's visit are listed. The French version of this pamphlet 1911, "Timbre de nitroglycérine", is also available.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0251
Less detail

32 records – page 1 of 2.